Baseline survey on drug resistance of Mycobacterium tuberculosis in Xi’an city
Author:
Affiliation:

Clc Number:

R521

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Comments
    Abstract:

    ObjectiveTo investigate the baseline condition of initial and acquired drug resistance in patients with pulmonary tuberculosis in Xi’an city, and provide a scientific basis for the prevention and control of drugresistant tuberculosis.MethodsPatients with positive Mycobacterium tuberculosis(MT) culture and received initial treatment and retreatment in tuberculosis clinics of 14 districts (counties) in Xi’an  and Xi’an Chest Hospital in 2015 were included in the study, antimicrobial susceptibility testing of 4 kinds of firstline antituberculosis drugs were performed.ResultsThe overall drug resistance rate of MT in Xi’an city was 31.9%, multidrug resistance rate (MDR) was 7.0%. Drug resistance rate and MDR in initial treatment group were 27.3% and 3.5% respectively, in retreatment group were 59.5% and 28.6% respectively, drug resistance rate and MDR in retreatment group were both higher than initial treatment group (both P<0.001).ConclusionThe overall drug resistance rate of pulmonary tuberculosis patients in Xi’an city is lower than the whole nation, but MDR is slightly higher than the national level, although TB prevention and control work has achieved some success, the situation is still serious, the management of patients with initial treatment should be strengthened to reduce the occurrence of drug resistance.

    Reference
    Related
Get Citation

李于于,曾令城,柳巍.西安市结核分枝杆菌耐药基线调查[J].中国感染控制杂志英文版,2016,15(12):952-955. DOI:10.3969/j. issn.1671-9638.2016.12.014.
LI Yuyu, ZENG Lingcheng, LIU Wei. Baseline survey on drug resistance of Mycobacterium tuberculosis in Xi’an city[J]. Chin J Infect Control, 2016,15(12):952-955. DOI:10.3969/j. issn.1671-9638.2016.12.014.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:April 12,2016
  • Revised:June 03,2016
  • Adopted:
  • Online: December 30,2016
  • Published: